位置:首页 > 蛋白库 > C1QBP_BOVIN
C1QBP_BOVIN
ID   C1QBP_BOVIN             Reviewed;         278 AA.
AC   Q3T0B6;
DT   30-MAY-2006, integrated into UniProtKB/Swiss-Prot.
DT   11-OCT-2005, sequence version 1.
DT   03-AUG-2022, entry version 99.
DE   RecName: Full=Complement component 1 Q subcomponent-binding protein, mitochondrial;
DE   Flags: Precursor;
GN   Name=C1QBP;
OS   Bos taurus (Bovine).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Laurasiatheria; Artiodactyla; Ruminantia; Pecora; Bovidae;
OC   Bovinae; Bos.
OX   NCBI_TaxID=9913;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=Crossbred X Angus; TISSUE=Ileum;
RG   NIH - Mammalian Gene Collection (MGC) project;
RL   Submitted (AUG-2005) to the EMBL/GenBank/DDBJ databases.
CC   -!- FUNCTION: Is believed to be a multifunctional and multicompartmental
CC       protein involved in inflammation and infection processes, ribosome
CC       biogenesis, protein synthesis in mitochondria, regulation of apoptosis,
CC       transcriptional regulation and pre-mRNA splicing. At the cell surface
CC       is thought to act as an endothelial receptor for plasma proteins of the
CC       complement and kallikrein-kinin cascades. Putative receptor for C1q;
CC       specifically binds to the globular 'heads' of C1q thus inhibiting C1;
CC       may perform the receptor function through a complex with C1qR/CD93. In
CC       complex with cytokeratin-1/KRT1 is a high affinity receptor for
CC       kininogen-1/HMWK. Can also bind other plasma proteins, such as
CC       coagulation factor XII leading to its autoactivation. May function to
CC       bind initially fluid kininogen-1 to the cell membrane. The secreted
CC       form may enhance both extrinsic and intrinsic coagulation pathways. It
CC       is postulated that the cell surface form requires docking with
CC       transmembrane proteins for downstream signaling which might be specific
CC       for a cell-type or response. By acting as C1q receptor is involved in
CC       chemotaxis of immature dendritic cells and neutrophils and is proposed
CC       to signal through CD209/DC-SIGN on immature dendritic cells, through
CC       integrin alpha-4/beta-1 during trophoblast invasion of the decidua, and
CC       through integrin beta-1 during endothelial cell adhesion and spreading.
CC       Signaling involved in inhibition of innate immune response is
CC       implicating the PI3K-AKT/PKB pathway. Required for protein synthesis in
CC       mitochondria. In mitochondrial translation may be involved in formation
CC       of functional 55S mitoribosomes; the function seems to involve its RNA-
CC       binding activity. May be involved in the nucleolar ribosome maturation
CC       process; the function may involve the exchange of FBL for RRP1 in the
CC       association with pre-ribosome particles. Involved in regulation of RNA
CC       splicing by inhibiting the RNA-binding capacity of SRSF1 and its
CC       phosphorylation. Is required for the nuclear translocation of splicing
CC       factor U2AF1L4. Involved in regulation of CDKN2A- and HRK-mediated
CC       apoptosis. May be involved in regulation of FOXC1 transcriptional
CC       activity and NFY/CCAAT-binding factor complex-mediated transcription.
CC       May play a role in antibacterial defense.
CC       {ECO:0000250|UniProtKB:Q07021}.
CC   -!- SUBUNIT: Homotrimer; three monomers form a donut-shaped structure with
CC       an unusually asymmetric charge distribution on the surface. Interacts
CC       with CDK13, HRK, VTN, NFYB, ADRA1B, FOXC1, DDX21, DDX50, NCL, SRSF1 and
CC       SRSF9. Interacts with CD93; the association may represent a cell
CC       surface C1q receptor. Interacts with KRT1; the association represents a
CC       cell surface kininogen receptor. Interacts with CD209; the interaction
CC       is indicative for a C1q:C1QBP:CD209 signaling complex. Interacts with
CC       FBL and RRP1; the respective interactions with C1QBP are competitive.
CC       Probably associates with the mitoribosome. Interacts with MAVS; the
CC       interaction occurs upon viral transfection. Interacts with PPIF.
CC       Interacts with U2AF1L4. Interacts with PLEKHN1. Interacts with VGF-
CC       derived peptide TLQP-21 (By similarity). {ECO:0000250|UniProtKB:O35658,
CC       ECO:0000250|UniProtKB:O35796, ECO:0000250|UniProtKB:Q07021}.
CC   -!- SUBCELLULAR LOCATION: Mitochondrion matrix
CC       {ECO:0000250|UniProtKB:Q07021}. Nucleus {ECO:0000250|UniProtKB:Q07021}.
CC       Cell membrane {ECO:0000250|UniProtKB:Q07021}; Peripheral membrane
CC       protein {ECO:0000250|UniProtKB:Q07021}; Extracellular side
CC       {ECO:0000250|UniProtKB:Q07021}. Secreted
CC       {ECO:0000250|UniProtKB:Q07021}. Cytoplasm
CC       {ECO:0000250|UniProtKB:Q07021}. Nucleus, nucleolus
CC       {ECO:0000250|UniProtKB:Q07021}. Note=Seems to be predominantly
CC       localized to mitochondria. Secreted by activated lymphocytes.
CC       {ECO:0000250|UniProtKB:Q07021}.
CC   -!- SIMILARITY: Belongs to the MAM33 family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; BC102464; AAI02465.1; -; mRNA.
DR   RefSeq; NP_001029699.1; NM_001034527.2.
DR   AlphaFoldDB; Q3T0B6; -.
DR   SMR; Q3T0B6; -.
DR   STRING; 9913.ENSBTAP00000013734; -.
DR   PaxDb; Q3T0B6; -.
DR   PeptideAtlas; Q3T0B6; -.
DR   PRIDE; Q3T0B6; -.
DR   Ensembl; ENSBTAT00000013734; ENSBTAP00000013734; ENSBTAG00000012739.
DR   GeneID; 518321; -.
DR   KEGG; bta:518321; -.
DR   CTD; 708; -.
DR   VEuPathDB; HostDB:ENSBTAG00000012739; -.
DR   VGNC; VGNC:26618; C1QBP.
DR   eggNOG; KOG4024; Eukaryota.
DR   GeneTree; ENSGT00390000018406; -.
DR   HOGENOM; CLU_083914_0_0_1; -.
DR   InParanoid; Q3T0B6; -.
DR   OMA; YEHTAYV; -.
DR   OrthoDB; 888304at2759; -.
DR   TreeFam; TF315160; -.
DR   Reactome; R-BTA-140837; Intrinsic Pathway of Fibrin Clot Formation.
DR   Reactome; R-BTA-8980692; RHOA GTPase cycle.
DR   Reactome; R-BTA-9013106; RHOC GTPase cycle.
DR   Proteomes; UP000009136; Chromosome 19.
DR   Bgee; ENSBTAG00000012739; Expressed in oocyte and 106 other tissues.
DR   GO; GO:0009986; C:cell surface; IBA:GO_Central.
DR   GO; GO:0005737; C:cytoplasm; ISS:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IEA:Ensembl.
DR   GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR   GO; GO:0005759; C:mitochondrial matrix; IEA:UniProtKB-SubCell.
DR   GO; GO:0005730; C:nucleolus; IEA:UniProtKB-SubCell.
DR   GO; GO:0005634; C:nucleus; ISS:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; IBA:GO_Central.
DR   GO; GO:0032991; C:protein-containing complex; IDA:AgBase.
DR   GO; GO:0031690; F:adrenergic receptor binding; ISS:UniProtKB.
DR   GO; GO:0001849; F:complement component C1q complex binding; ISS:UniProtKB.
DR   GO; GO:0005540; F:hyaluronic acid binding; ISS:UniProtKB.
DR   GO; GO:0030984; F:kininogen binding; ISS:UniProtKB.
DR   GO; GO:0097177; F:mitochondrial ribosome binding; ISS:UniProtKB.
DR   GO; GO:0003729; F:mRNA binding; ISS:UniProtKB.
DR   GO; GO:0003714; F:transcription corepressor activity; ISS:UniProtKB.
DR   GO; GO:0006915; P:apoptotic process; IEA:UniProtKB-KW.
DR   GO; GO:0006958; P:complement activation, classical pathway; IEA:UniProtKB-KW.
DR   GO; GO:0045087; P:innate immune response; IEA:UniProtKB-KW.
DR   GO; GO:0042256; P:mature ribosome assembly; ISS:UniProtKB.
DR   GO; GO:0006397; P:mRNA processing; IEA:UniProtKB-KW.
DR   GO; GO:0050687; P:negative regulation of defense response to virus; ISS:UniProtKB.
DR   GO; GO:0032689; P:negative regulation of interferon-gamma production; ISS:UniProtKB.
DR   GO; GO:0032695; P:negative regulation of interleukin-12 production; ISS:UniProtKB.
DR   GO; GO:0039534; P:negative regulation of MDA-5 signaling pathway; ISS:UniProtKB.
DR   GO; GO:0048025; P:negative regulation of mRNA splicing, via spliceosome; ISS:UniProtKB.
DR   GO; GO:0039536; P:negative regulation of RIG-I signaling pathway; ISS:UniProtKB.
DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; ISS:UniProtKB.
DR   GO; GO:0014065; P:phosphatidylinositol 3-kinase signaling; ISS:UniProtKB.
DR   GO; GO:0043065; P:positive regulation of apoptotic process; ISS:UniProtKB.
DR   GO; GO:0045785; P:positive regulation of cell adhesion; ISS:UniProtKB.
DR   GO; GO:2000510; P:positive regulation of dendritic cell chemotaxis; ISS:UniProtKB.
DR   GO; GO:0070131; P:positive regulation of mitochondrial translation; ISS:UniProtKB.
DR   GO; GO:0090023; P:positive regulation of neutrophil chemotaxis; ISS:UniProtKB.
DR   GO; GO:0051897; P:positive regulation of protein kinase B signaling; ISS:UniProtKB.
DR   GO; GO:1900026; P:positive regulation of substrate adhesion-dependent cell spreading; ISS:UniProtKB.
DR   GO; GO:1901165; P:positive regulation of trophoblast cell migration; ISS:UniProtKB.
DR   GO; GO:0030449; P:regulation of complement activation; ISS:UniProtKB.
DR   GO; GO:0008380; P:RNA splicing; IEA:UniProtKB-KW.
DR   Gene3D; 3.10.280.10; -; 1.
DR   InterPro; IPR003428; MAM33.
DR   InterPro; IPR036561; MAM33_sf.
DR   PANTHER; PTHR10826; PTHR10826; 1.
DR   Pfam; PF02330; MAM33; 1.
DR   SUPFAM; SSF54529; SSF54529; 1.
PE   2: Evidence at transcript level;
KW   Acetylation; Adaptive immunity; Apoptosis; Cell membrane;
KW   Complement pathway; Cytoplasm; Immunity; Innate immunity; Membrane;
KW   Mitochondrion; mRNA processing; mRNA splicing; Nucleus; Phosphoprotein;
KW   Reference proteome; Ribosome biogenesis; Secreted; Transcription;
KW   Transcription regulation; Transit peptide.
FT   TRANSIT         1..70
FT                   /note="Mitochondrion"
FT                   /evidence="ECO:0000250"
FT   CHAIN           71..278
FT                   /note="Complement component 1 Q subcomponent-binding
FT                   protein, mitochondrial"
FT                   /id="PRO_0000238676"
FT   REGION          73..90
FT                   /note="C1q binding"
FT                   /evidence="ECO:0000250"
FT   REGION          136..164
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          166..209
FT                   /note="Interaction with MAVS"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         84
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q07021"
FT   MOD_RES         88
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q07021"
FT   MOD_RES         91
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:O35658"
FT   MOD_RES         185
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:Q07021"
FT   MOD_RES         197
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q07021"
FT   MOD_RES         201
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q07021"
FT   MOD_RES         210
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q07021"
SQ   SEQUENCE   278 AA;  30606 MW;  17C9ED0C3A426B15 CRC64;
     MFQLLRCVPR VLGTAVAGLR AAAPSLPRLQ PASRPCARPF GLLSVRARSV QLPGLLKPRG
     PCACGCGCSG LHTEGDKAFV DFLSDEIKEE KKIQKYKSLP KMSGGWELEV NGTEAKLVRK
     VAGEKITVTF NINNSIPPAF GGEEEEPSQG QKAEEQEPEL TSTPNFVVEV TKDGSSKALV
     LDCHYPEDEI GQEDDQSDIF SIKEVSFQAT GESDWKDTNY TLNTDSLDWG LYDHLMDFLA
     DRGVDNTFAD ELVELSTALE HQEYISFLED LKGFVKSK
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024